Fosfestrol

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L02AA04

CAS registry number (Chemical Abstracts Service)

0000522-40-7

Chemical Formula

C18-H22-O8-P2

Molecular Weight

428

Therapeutic Categories

Antineoplastic agent

Estrogen

Chemical Names

(E)-4,4'-(1,2-Diethylvinylene)bis(phenyl dihydrogen orthophosphate) (BAN)

(E)-4,4'-(Hex-3-ene-3,4-diyl)bis(phenyl dihydrogen phosphate) (JP)

4,4'-[(1E)-1,2-Diethyl-1,2-ethenediyl]bisphenol bis(dihydrogen phosphate)

α,α'-Diethyl-(E)-4,4'-stilbenediol bis(dihydrogen phosphate) (USP)

α,α'-Diethyl-4,4'-stilbenediol bis(di-H phosphate) (WHO)

Phenol, 4,4'-(1,2-diethyl-1,2-ethenediyl)bis-, bis(dihydrogen phosphate), (E)- (USP)

Foreign Names

• Fosfestrolum (Latin)
• Fosfestrol (German)
• Fosfestrol (French)
• Fosfestrol (Spanish)

Generic Names

• Fosfestrol (OS: BAN, JAN)
• Fosfestrolo (OS: DCIT)
• Diethyldihydroxystilbene diphosphate (IS)
• Diethylstilbestryl diphosphate (IS)
• St 52-Asta (IS)
• Stilbestrol diphosphate (IS)
• UNII-A0E0NMA80F (IS)
• Diethylstilbestrol Diphosphate (PH: USP 32)
• Fosfestrol (PH: JP XV)
• Fosfestrol Sodium (OS: BANM)
• ST-52 (IS)
• Stilbostatin (IS)
• Fosfestrol Sodium (PH: BP 2010)

Brand Names

• Honvan
  ASTA Medica, Sri Lanka; Baxter, Luxembourg; Baxter Oncology, Oman; German Remedies, India; Sanofi-Aventis, Bangladesh

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
JP	The Japanese Pharmacopoeia
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USP	Pharmacopoeia of the United States
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Valpro AL

Valpro AL may be available in the countries listed below.

Ingredient matches for Valpro AL

Valproic Acid

Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Valpro AL in the following countries:

• Germany

International Drug Name Search

Bupisen

Bupisen may be available in the countries listed below.

Ingredient matches for Bupisen

Bupivacaine

Bupivacaine hydrochloride (a derivative of Bupivacaine) is reported as an ingredient of Bupisen in the following countries:

• Italy

International Drug Name Search

Cytarabine

In the US, Cytarabine (cytarabine systemic) is a member of the drug class antimetabolites and is used to treat Acute Myeloid Leukemia, Acute Nonlymphocytic Leukemia, Chronic Myelogenous Leukemia, Leukemia, Meningeal Leukemia and Non-Hodgkin's Lymphoma.

US matches:

• Cytarabine


• Cytarabine liposomal


• Cytarabine liposome Intrathecal

UK matches:

• Cytarabine Injection Solution (SPC)
• Cytarabine Injection Solution 100mg/ml (Hospira UK Ltd) (SPC)
• Cytarabine Injection Solution 20mg/ml (SPC)
• Cytarabine Injection Solution 20mg/ml and 100mg/ml (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01BC01

CAS registry number (Chemical Abstracts Service)

0000147-94-4

Chemical Formula

C9-H13-N3-O5

Molecular Weight

243

Therapeutic Category

Antineoplastic agent

Chemical Name

2(1H)-Pyrimidinone, 4-amino-1-ß-D-arabinofuranosyl-

Foreign Names

• Cytarabinum (Latin)
• Cytarabin (German)
• Cytarabine (French)
• Citarabina (Spanish)

Generic Names

• Citarabina (OS: DCIT)
• Cytarabine (OS: USAN, DCF, JAN, BAN)
• Arabinosylcytosine (IS)
• NSC 63878 (IS)
• U 19920 (IS)
• Cytarabin (PH: Ph. Eur. 6)
• Cytarabine (PH: BP 2010, Ph. Eur. 6, Ph. Int. 4, USP 32, JP XV)
• Cytarabinum (PH: Ph. Int. 4, Ph. Eur. 6)
• Cytarabine Hydrochloride (OS: USAN)
• AC 1075 (IS)
• ARA-C (IS)
• U 19920 A (IS)
• Cytarabine ocfosfate (IS)

Brand Names

• Alexan
  Ebewe, Austria; Ebewe, Bulgaria; Ebewe, Czech Republic; Ebewe, Germany; Ebewe, Georgia; Ebewe, Hungary; Ebewe, Malta; Ebewe, Netherlands; Ebewe, Oman; Ebewe, Poland; Ebewe, Serbia; Ebewe, Russian Federation; Ebewe, Tunisia; Ebewe, Vietnam; Ebewe Pharma, Slovakia; Eczacibasi Baxter, Turkey; Ferraz, Portugal; Mack, Israel; Mack, Romania; NeoCorp, Germany; Pfizer, Chile; Pharmafrica, South Africa



• Arabine
  Hospira Nordic, Denmark; Hospira Nordic, Sweden



• Ara-cell
  Cell pharm, Germany; Stada, Austria



• Aracytin
  Pfizer, Brazil; Pfizer, Chile; Pfizer, Colombia; Pfizer, Greece; Pfizer, Italy



• Aracytine
  Pfizer, France; Pfizer, Tunisia



• Citabion
  Medicus, Greece



• Citafam
  Richmond, Argentina



• Citafan
  Richmond, Peru



• Citagenin
  Ivax, Argentina; Ivax, Peru



• Citarabina Filaxis
  Filaxis, Argentina



• Citarabina Hospira
  Hospira, Italy



• Citarabina Martian
  LKM, Argentina



• Citarabina Microsules
  Microsules, Argentina



• Citarabina Pfizer
  Pfizer, Spain



• Citarabina Pharmacia
  Pfizer, Spain



• Citarabina
  AC Farma, Peru; Baxter, Chile; Kampar, Chile; Tecnofarma, Colombia; World Pharma, Peru



• Cylocide N
  Nippon Shinyaku, Japan



• Cylocide
  Nippon Shinyaku, Japan; Nippon Shinyaku, Taiwan



• Cyta-Cell
  Eurogenerics, Luxembourg



• Cytarabin Hexal
  Hexal, Germany



• Cytarabin Stada
  Stada, Austria



• Cytarabin
  Pfizer, Norway



• Cytarabine CF
  Centrafarm, Netherlands



• Cytarabine DBL
  Hospira, Australia; Hospira, Indonesia; Hospira, Singapore; Mayne, Hong Kong; Mayne, Malaysia; Orna, Turkey; Tempo Scan Pacific, Indonesia



• Cytarabine Faulding
  Pharmaplan, South Africa



• Cytarabine Hospira
  Hospira, Belgium; Hospira, Netherlands



• Cytarabine Injection
  APP, United States; Mayne, United States; PfizerPerth, Australia



• Cytarabine Pfizer
  Pfizer, Denmark; Pfizer, Finland; Pfizer, Iceland; Pfizer, Sweden



• Cytarabine Stada
  Cell Pharm, Bulgaria



• Cytarabine
  Bedford, United States; Generics, Israel; Genmedix, Israel; Hospira, Canada; Hospira, Malta; Hospira, New Zealand; Hospira, Taiwan; Hospira, United States; Mayne, Ireland; Onko-Koçsel, Turkey; Pfizer, United Kingdom



• Cytarabine-Mayne
  Hospira, Luxembourg



• Cytarine
  Dabur, India; Dabur, Myanmar; GP Pharm, Peru



• Cytosar Cytosafe Vial
  Pharmacia, Luxembourg



• Cytosar
  Pfizer, Belgium; Pfizer, Bulgaria; Pfizer, Bulgaria; Pfizer, Bahrain; Pfizer, Canada; Pfizer, Switzerland; Pfizer, Colombia; Pfizer, Czech Republic; Pfizer, Estonia; Pfizer, Georgia; Pfizer, Hong Kong; Pfizer, Croatia (Hrvatska); Pfizer, Hungary; Pfizer, Israel; Pfizer, Lithuania; Pfizer, Luxembourg; Pfizer, Latvia; Pfizer, Oman; Pfizer, Peru; Pfizer, Poland; Pfizer, Portugal; Pfizer, Romania; Pfizer, Serbia; Pfizer, Russian Federation; Pfizer, Singapore; Pfizer, Taiwan; Pfizer, Venezuela; Pfizer, Vietnam; Pfizer, South Africa; Pharmacia, Bulgaria; Pharmacia, China; Pharmacia, Ghana; Pharmacia, Kenya; Pharmacia, Liberia; Pharmacia, Slovakia; Pharmacia, Sierra Leone; Pharmacia, Tanzania; Pharmacia, Uganda; Pharmacia, Zimbabwe; Upjohn, Bulgaria



• Cytosar-U
  Pfizer, Indonesia; Pfizer, Malaysia; Pfizer, United States



• Cytostar
  Pfizer, Thailand



• Cytrabine
  Mayne, New Zealand



• DepoCyt
  Enzon, United States



• DepoCyte
  Mundipharma, Belgium; Mundipharma, Switzerland; Mundipharma, Germany; Mundipharma, Spain; Mundipharma, Finland; Mundipharma, France; Mundipharma, Italy; Mundipharma, Sweden; Napp, United Kingdom; Skye, Austria; Skye, Iceland; Skye, Luxembourg; Skye, Netherlands; Skye, Slovakia; Skyepharma, Denmark; Skyepharma, Norway; Skyepharma, Poland; Skyepharma, Slovenia



• Laracit
  Chile, Chile; Lemery, Mexico



• Leucyt
  Dabur, Philippines



• Medsara
  Asofarma, Mexico



• P&U Cytarabine
  Pfizer, South Africa



• Tabine
  Korea United Pharm, Georgia



• Citab
  Eurofarma, Brazil



• Starasid
  Nippon Kayaku, Japan

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
SPC	Summary of Product Characteristics (UK)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

IntronA

IntronA may be available in the countries listed below.

Ingredient matches for IntronA

Interferon alfa

Interferon alfa Interferon alfa-2b (Arg-23; His-34) (a derivative of Interferon alfa) is reported as an ingredient of IntronA in the following countries:

• Finland


• France


• Greece


• Iceland


• Ireland


• Italy


• Spain


• Sweden


• Tunisia

International Drug Name Search